# Antiretroviral Therapy for Advanced HIV Disease in South Africa

> **NCT00342355** · PHASE4 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 1771 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Zidovudine
- **DRUG:** Stavudine
- **DRUG:** Didanosine
- **DRUG:** Lamivudine
- **DRUG:** Efavirenz
- **DRUG:** Lopinavir/Ritonavir

## Key facts

- **NCT ID:** NCT00342355
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-08
- **Target enrollment:** 1771 (ACTUAL)
- **Last updated:** 2013-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00342355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00342355, "Antiretroviral Therapy for Advanced HIV Disease in South Africa". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00342355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*